Weaver Consulting Group - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 49 filers reported holding RECRO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
Weaver Consulting Group ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$9,473
-57.4%
20,1990.0%0.00%
-60.0%
Q2 2023$22,219
-2.7%
20,199
+5.2%
0.01%0.0%
Q1 2023$22,847
-10.5%
19,199
+12.0%
0.01%
-23.1%
Q4 2022$25,531
-17.6%
17,135
-9.3%
0.01%
-27.8%
Q3 2022$31,000
+210.0%
18,885
+53.1%
0.02%
+200.0%
Q2 2022$10,00012,3330.01%
Other shareholders
RECRO PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders